Privia Health Group PRVA
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Privia Health Group (PRVA) Business Model and Operations Summary
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Key Insights
Privia Health Group (PRVA) Core Market Data and Business Metrics
Latest Closing Price
$22.88Market Cap
$2.76 BillionPrice-Earnings Ratio
381.33Total Outstanding Shares
120.51 Million SharesTotal Employees
1,140Dividend
No dividendIPO Date
April 29, 2021SIC Description
Services-health ServicesPrimary Exchange
NASDAQHeadquarters
950 N. Glebe Rd., Suite 700, Arlington, VA, 22203
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $34.65 Million |
| Net Cash Flow From Financing Activities | $1.49 Million |
| Net Cash Flow From Operating Activities | $33.15 Million |
| Net Cash Flow From Investing Activities | $0 |
| Net Cash Flow From Financing Activities, Continuing | $1.49 Million |
| Net Cash Flow From Operating Activities, Continuing | $33.15 Million |
Income Statement
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Nonoperating Income/Loss | $2.16 Million |
| Revenues | $437.92 Million |
| Income/Loss From Continuing Operations After Tax | $3.98 Million |
| Operating Expenses | $432.11 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $3.54 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $443,000 |
Comprehensive Income
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $3.98 Million |
| Other Comprehensive Income/Loss | $0 |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss | $3.98 Million |
Balance Sheet
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Other Current Liabilities | $472.54 Million |
| Liabilities | $483.38 Million |
| Accounts Payable | $6.93 Million |
| Fixed Assets | $1.46 Million |
| Equity Attributable To Noncontrolling Interest | $47.30 Million |
| Equity | $662.18 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||